CI
VIR icon

Capital International’s Vir Biotechnology VIR Stock Holding History

Capital International’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-28,214
Closed -$719K – 163
2022
Q2 		$719K Sell
28,214
-18,700
-40% -$437K 0.05% 148
2022
Q1 		$1.21M Hold
46,914
– – 0.07% 147
2021
Q4 		$1.96M Sell
46,914
-181
-0.4% -$7.09K 0.1% 129
2021
Q3 		$2.05M Sell
47,095
-644
-1% -$27.9K 0.11% 133
2021
Q2 		$2.26M Hold
47,739
– – 0.12% 132
2021
Q1 		$2.45M Sell
47,739
-1,234
-3% -$66.5K 0.15% 125
2020
Q4 		$1.31M Hold
48,973
– – 0.08% 139
2020
Q3 		$1.68M Buy
+48,973
New +$2.11M 0.11% 124

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International's VIR Position: Q3 2022 in Review

Capital International sold out of Vir Biotechnology (VIR) in Q3 2022, closing a stake of 28,214 shares — an estimated $719K sold.

Capital International first reported a position in VIR in Q3 2020 and held it in 8 quarters. The position peaked at $2.45M in Q1 2021. 221 funds tracked by Wall St. Rank hold VIR as of Q3 2022.

  • Capital International reported no remaining Vir Biotechnology position as of Q3 2022 after selling out during the quarter.
  • Capital International sold 28,214 Vir Biotechnology shares in Q3 2022, an estimated $719K.
  • Capital International first reported a position in Vir Biotechnology in Q3 2020 and held it in 8 quarters.
  • Capital International's Vir Biotechnology position peaked at $2.45M in Q1 2021.
  • 221 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2022.

Based on Capital International's 13F filing for Q3 2022, filed 14 Nov 2022.